Chonkungdang's sales in 3rd quarter rose 12%.

Published: 2004-11-08 06:56:00

Updated: 2004-11-08 06:56:00

Chonkundang reported that the sales up to the 3rd quarter this year at 136,500 million won grew up by 12.5% over the same period last year of 121,200 million won, the operating income by 36.3% up at 28.9 billion won, the ordinary income by 76.9% up at 17,100 million won and the net profit by 46.9...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK